VC-backed Pandion Therapeutics appoints CEO
Cambridge, Massachusetts-based Pandion Therapeutics, a biotech company focused on treating autoimmune and inflammatory disease, has named Dr. Rahul Kakkar as CEO and a member of its board of directors. Also, Pandion has promoted Dr. Jo Viney, a founder of the company, to president and chief scientific officer. And, Vikas Goyal joins Pandion as senior vice president of business development. Pandion's investors include Polaris Partners, Versant Ventures, Roche Venture Fund, SR One and BioInnovation Capital.
17 July 2019•6 mins read
